Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2015-04

AUTHORS

Thomas Yau, Paul N. Cheng, Pierre Chan, Li Chen, Jimmy Yuen, Roberta Pang, Sheung Tat Fan, Denys N. Wheatley, Ronnie T. Poon

ABSTRACT

This study was designed to evaluate the efficacy, safety profile, pharmacokinetics, pharmacodynamics and quality of life of pegylated recombinant human arginase 1 (Peg-rhAgr1) in patients with advanced hepatocellular carcinoma (HCC). Patients were given weekly doses of Peg-rhAgr1 (1600 U/kg). Tumour response was assessed every 8 weeks using RECIST 1.1 and modified RECIST criteria. A total of 20 patients were recruited, of whom 15 were deemed evaluable for treatment efficacy. Eighteen patients (90%) were hepatitis B carriers. Median age was 61.5 (range 30-75). Overall disease control rate was 13%, with 2 of the 15 patients achieving stable disease for >8 weeks. The median progression-free survival (PFS) was 1.7 (95% CI: 1.67-1.73) months, with median overall survival (OS) of all 20 enrolled patients being 5.2 (95% CI: 3.3-12.0) months. PFS was significantly prolonged in patients with adequate arginine depletion (ADD) >2 months versus those who had ≤2 months of ADD (6.4 versus 1.7 months; p = 0.01). The majority of adverse events (AEs) were grade 1/2 non-hematological toxicities. Transient liver dysfunctions (25%) were the most commonly reported serious AEs and likely due to disease progression. Pharmacokinetic and pharmacodynamic data showed that Peg-rhAgr1 induced rapid and sustained arginine depletion. The overall quality of life of the enrolled patients was well preserved. Peg-rhAgr1 is well tolerated with a good toxicity profile in patients with advanced HCC. A weekly dose of 1600 U/kg is sufficient to induce ADD. Significantly longer PFS times were recorded for patients who had ADD for >2 months. More... »

PAGES

496-504

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10637-014-0200-8

DOI

http://dx.doi.org/10.1007/s10637-014-0200-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1052798621

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25666409


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Area Under Curve", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Arginase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Hepatocellular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemistry, Pharmaceutical", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Half-Life", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Metabolic Clearance Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polyethylene Glycols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quality of Life", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recombinant Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Response Evaluation Criteria in Solid Tumors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Hong Kong", 
          "id": "https://www.grid.ac/institutes/grid.194645.b", 
          "name": [
            "Department of Medicine, The University of Hong Kong, Hong Kong, China", 
            "Centre for Cancer Research, The University of Hong Kong, Hong Kong, China", 
            "State Key Laboratory for Liver Research, The University of Hong Kong, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yau", 
        "givenName": "Thomas", 
        "id": "sg:person.011372244704.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011372244704.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Bio-Cancer Treatment International Limited, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cheng", 
        "givenName": "Paul N.", 
        "id": "sg:person.01002234745.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002234745.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ruttonjee Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416291.9", 
          "name": [
            "Department of Medicine, Ruttonjee Hospital, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chan", 
        "givenName": "Pierre", 
        "id": "sg:person.07742761162.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07742761162.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Bio-Cancer Treatment International Limited, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Li", 
        "id": "sg:person.01036172252.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036172252.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hong Kong Sanatorium and Hospital", 
          "id": "https://www.grid.ac/institutes/grid.414329.9", 
          "name": [
            "Hong Kong Sanatorium Hospital, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yuen", 
        "givenName": "Jimmy", 
        "id": "sg:person.01353440362.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353440362.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Hong Kong", 
          "id": "https://www.grid.ac/institutes/grid.194645.b", 
          "name": [
            "Centre for Cancer Research, The University of Hong Kong, Hong Kong, China", 
            "Department of Surgery, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pang", 
        "givenName": "Roberta", 
        "id": "sg:person.013420356062.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013420356062.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Hong Kong", 
          "id": "https://www.grid.ac/institutes/grid.194645.b", 
          "name": [
            "Centre for Cancer Research, The University of Hong Kong, Hong Kong, China", 
            "State Key Laboratory for Liver Research, The University of Hong Kong, Hong Kong, China", 
            "Department of Surgery, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fan", 
        "givenName": "Sheung Tat", 
        "id": "sg:person.01111046126.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01111046126.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Bio-Cancer Treatment International Limited, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wheatley", 
        "givenName": "Denys N.", 
        "id": "sg:person.01335216507.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335216507.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Hong Kong", 
          "id": "https://www.grid.ac/institutes/grid.194645.b", 
          "name": [
            "Centre for Cancer Research, The University of Hong Kong, Hong Kong, China", 
            "State Key Laboratory for Liver Research, The University of Hong Kong, Hong Kong, China", 
            "Department of Surgery, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Poon", 
        "givenName": "Ronnie T.", 
        "id": "sg:person.07501676632.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07501676632.96"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1111/j.1755-148x.2010.00798.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012724924"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000658-200204000-00004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013218119"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000658-200204000-00004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013218119"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1053-4296(03)00031-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017567845"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1053-4296(03)00031-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017567845"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.canlet.2008.11.031", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017999696"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(08)70285-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018829845"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1475-2867-9-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018933074", 
          "https://doi.org/10.1186/1475-2867-9-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2009-12-258822", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019505412"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00008390-199209000-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020661938"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00008390-199209000-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020661938"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00008390-199209000-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020661938"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0168-8278(01)00130-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021007716"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/dji315", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021808122"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2012.44.5643", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022849249"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.20057", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023655716"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10637-012-9807-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025303725", 
          "https://doi.org/10.1007/s10637-012-9807-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-06-1945", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026108300"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.22322", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026137659"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6605856", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027168571", 
          "https://doi.org/10.1038/sj.bjc.6605856"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.canlet.2004.10.050", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027789545"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00001813-200410000-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027805675"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00001813-200410000-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027805675"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2012.45.8372", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027910211"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/92.3.205", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032301848"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.2910510213", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038899862"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.23878", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040510533"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1756-8722-5-17", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041830204", 
          "https://doi.org/10.1186/1756-8722-5-17"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.1440", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043886019"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.23723", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047559222"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.11.120", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049804785"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0708857", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053513212"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2174/156800912803988002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069191266"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074500177", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075086476", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-04", 
    "datePublishedReg": "2015-04-01", 
    "description": "This study was designed to evaluate the efficacy, safety profile, pharmacokinetics, pharmacodynamics and quality of life of pegylated recombinant human arginase 1 (Peg-rhAgr1) in patients with advanced hepatocellular carcinoma (HCC). Patients were given weekly doses of Peg-rhAgr1 (1600 U/kg). Tumour response was assessed every 8 weeks using RECIST 1.1 and modified RECIST criteria. A total of 20 patients were recruited, of whom 15 were deemed evaluable for treatment efficacy. Eighteen patients (90%) were hepatitis B carriers. Median age was 61.5 (range 30-75). Overall disease control rate was 13%, with 2 of the 15 patients achieving stable disease for >8 weeks. The median progression-free survival (PFS) was 1.7 (95% CI: 1.67-1.73) months, with median overall survival (OS) of all 20 enrolled patients being 5.2 (95% CI: 3.3-12.0) months. PFS was significantly prolonged in patients with adequate arginine depletion (ADD) >2 months versus those who had \u22642 months of ADD (6.4 versus 1.7 months; p\u2009=\u20090.01). The majority of adverse events (AEs) were grade 1/2 non-hematological toxicities. Transient liver dysfunctions (25%) were the most commonly reported serious AEs and likely due to disease progression. Pharmacokinetic and pharmacodynamic data showed that Peg-rhAgr1 induced rapid and sustained arginine depletion. The overall quality of life of the enrolled patients was well preserved. Peg-rhAgr1 is well tolerated with a good toxicity profile in patients with advanced HCC. A weekly dose of 1600 U/kg is sufficient to induce ADD. Significantly longer PFS times were recorded for patients who had ADD for >2 months.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s10637-014-0200-8", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094201", 
        "issn": [
          "0167-6997", 
          "1573-0646"
        ], 
        "name": "Investigational New Drugs", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "33"
      }
    ], 
    "name": "Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma", 
    "pagination": "496-504", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "fb7edd20ac70be54e17006b72bb44b27f06d1537115edcd96ef363c494234538"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25666409"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8309330"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10637-014-0200-8"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1052798621"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10637-014-0200-8", 
      "https://app.dimensions.ai/details/publication/pub.1052798621"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T10:33", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000349_0000000349/records_113661_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs10637-014-0200-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10637-014-0200-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10637-014-0200-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10637-014-0200-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10637-014-0200-8'


 

This table displays all metadata directly associated to this object as RDF triples.

320 TRIPLES      21 PREDICATES      81 URIs      43 LITERALS      31 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10637-014-0200-8 schema:about N05c42937517b4c4eab973ed27b8dcba9
2 N0c493fc0126e46d9884386fcf109c298
3 N27ad877039b149d7bd9dfa79655ffb50
4 N2af05b14ba184d02a59db0bc2540ad5b
5 N371eafec0c9949e787b4b739ec39e4e3
6 N385b71b8f4934c54b4000f56ee74a776
7 N59eda6a9877a42e4830174b84687f248
8 N5d06be4361b14603b1aa42517efd107a
9 N7b8d2c1c290049148003c95f803f4469
10 N8a64f40209de4739ad200966e7933a36
11 N92196dc2268842ca82a854e7865c64ae
12 N9398371741de4c20a238f81de4bd9607
13 N99599cdf650e4b7bb94307e6cab40d9c
14 N9b4125fcd98f44e880c777fdd49d04c6
15 Nab209c9d57cf4c3d8b843b4180eb8f81
16 Nb34c4925ddcc4e249144ff4ec234f7d0
17 Nc31f333db8184a0989e01154455477b3
18 Nc9604360bd9d420f8f095dd549f08d94
19 Nc9f6ca379747412b815232eaf207c9e7
20 Nd03ae116e26a4a739b9ab8f4bab0024d
21 Nd9cc458be1554c77aad4643201146309
22 Ne72a8a14799546a0911aa3f08091dd15
23 anzsrc-for:11
24 anzsrc-for:1103
25 schema:author N9cab48efd3564640b7aa7ac72bb8204b
26 schema:citation sg:pub.10.1007/s10637-012-9807-9
27 sg:pub.10.1038/sj.bjc.6605856
28 sg:pub.10.1186/1475-2867-9-9
29 sg:pub.10.1186/1756-8722-5-17
30 https://app.dimensions.ai/details/publication/pub.1074500177
31 https://app.dimensions.ai/details/publication/pub.1075086476
32 https://doi.org/10.1002/cncr.20057
33 https://doi.org/10.1002/cncr.23878
34 https://doi.org/10.1002/ijc.1440
35 https://doi.org/10.1002/ijc.22322
36 https://doi.org/10.1002/ijc.23723
37 https://doi.org/10.1002/ijc.2910510213
38 https://doi.org/10.1016/j.canlet.2004.10.050
39 https://doi.org/10.1016/j.canlet.2008.11.031
40 https://doi.org/10.1016/s0168-8278(01)00130-1
41 https://doi.org/10.1016/s1053-4296(03)00031-6
42 https://doi.org/10.1016/s1470-2045(08)70285-7
43 https://doi.org/10.1056/nejmoa0708857
44 https://doi.org/10.1093/jnci/92.3.205
45 https://doi.org/10.1093/jnci/dji315
46 https://doi.org/10.1097/00000658-200204000-00004
47 https://doi.org/10.1097/00001813-200410000-00002
48 https://doi.org/10.1097/00008390-199209000-00007
49 https://doi.org/10.1111/j.1755-148x.2010.00798.x
50 https://doi.org/10.1158/0008-5472.can-06-1945
51 https://doi.org/10.1182/blood-2009-12-258822
52 https://doi.org/10.1200/jco.2004.11.120
53 https://doi.org/10.1200/jco.2012.44.5643
54 https://doi.org/10.1200/jco.2012.45.8372
55 https://doi.org/10.2174/156800912803988002
56 schema:datePublished 2015-04
57 schema:datePublishedReg 2015-04-01
58 schema:description This study was designed to evaluate the efficacy, safety profile, pharmacokinetics, pharmacodynamics and quality of life of pegylated recombinant human arginase 1 (Peg-rhAgr1) in patients with advanced hepatocellular carcinoma (HCC). Patients were given weekly doses of Peg-rhAgr1 (1600 U/kg). Tumour response was assessed every 8 weeks using RECIST 1.1 and modified RECIST criteria. A total of 20 patients were recruited, of whom 15 were deemed evaluable for treatment efficacy. Eighteen patients (90%) were hepatitis B carriers. Median age was 61.5 (range 30-75). Overall disease control rate was 13%, with 2 of the 15 patients achieving stable disease for >8 weeks. The median progression-free survival (PFS) was 1.7 (95% CI: 1.67-1.73) months, with median overall survival (OS) of all 20 enrolled patients being 5.2 (95% CI: 3.3-12.0) months. PFS was significantly prolonged in patients with adequate arginine depletion (ADD) >2 months versus those who had ≤2 months of ADD (6.4 versus 1.7 months; p = 0.01). The majority of adverse events (AEs) were grade 1/2 non-hematological toxicities. Transient liver dysfunctions (25%) were the most commonly reported serious AEs and likely due to disease progression. Pharmacokinetic and pharmacodynamic data showed that Peg-rhAgr1 induced rapid and sustained arginine depletion. The overall quality of life of the enrolled patients was well preserved. Peg-rhAgr1 is well tolerated with a good toxicity profile in patients with advanced HCC. A weekly dose of 1600 U/kg is sufficient to induce ADD. Significantly longer PFS times were recorded for patients who had ADD for >2 months.
59 schema:genre research_article
60 schema:inLanguage en
61 schema:isAccessibleForFree false
62 schema:isPartOf N8fbdf6ab2ab6441ebd99f04ce40b42f7
63 Nea9811ee600f4903a2163f18e911484b
64 sg:journal.1094201
65 schema:name Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma
66 schema:pagination 496-504
67 schema:productId N20c36624d88d49fdbbae18690ebfe896
68 Nb44eab0271e64a79a1841e478fd3233b
69 Nb8c37b3c20004f55b4c1c752026ad3fc
70 Ncbd093acada441b6b1ccb19ca35750ab
71 Nd8d93d4188ba4c2c8de0ecf89a6af675
72 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052798621
73 https://doi.org/10.1007/s10637-014-0200-8
74 schema:sdDatePublished 2019-04-11T10:33
75 schema:sdLicense https://scigraph.springernature.com/explorer/license/
76 schema:sdPublisher Nc493f2ed2ed0448cb8ac866cab000645
77 schema:url https://link.springer.com/10.1007%2Fs10637-014-0200-8
78 sgo:license sg:explorer/license/
79 sgo:sdDataset articles
80 rdf:type schema:ScholarlyArticle
81 N0346dd29b07941929d21ea438fd72cb7 rdf:first sg:person.01111046126.83
82 rdf:rest N1645c7358da7442d86d89f8d635ec9d7
83 N05c42937517b4c4eab973ed27b8dcba9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Chemistry, Pharmaceutical
85 rdf:type schema:DefinedTerm
86 N0c493fc0126e46d9884386fcf109c298 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Antineoplastic Agents
88 rdf:type schema:DefinedTerm
89 N1645c7358da7442d86d89f8d635ec9d7 rdf:first sg:person.01335216507.83
90 rdf:rest Nc5ceb3c7494e4a7a86300458012db02a
91 N20c36624d88d49fdbbae18690ebfe896 schema:name nlm_unique_id
92 schema:value 8309330
93 rdf:type schema:PropertyValue
94 N27ad877039b149d7bd9dfa79655ffb50 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Arginase
96 rdf:type schema:DefinedTerm
97 N2af05b14ba184d02a59db0bc2540ad5b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Quality of Life
99 rdf:type schema:DefinedTerm
100 N371eafec0c9949e787b4b739ec39e4e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Metabolic Clearance Rate
102 rdf:type schema:DefinedTerm
103 N385b71b8f4934c54b4000f56ee74a776 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Half-Life
105 rdf:type schema:DefinedTerm
106 N59eda6a9877a42e4830174b84687f248 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Humans
108 rdf:type schema:DefinedTerm
109 N5d06be4361b14603b1aa42517efd107a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Female
111 rdf:type schema:DefinedTerm
112 N659556c3256a4810b66f7d0767804956 schema:name Bio-Cancer Treatment International Limited, Hong Kong, China
113 rdf:type schema:Organization
114 N74db9d927d8642a18d9626c9bcf17f5d rdf:first sg:person.07742761162.25
115 rdf:rest Nbf966be00f4d472d8d5d84e05f40b87c
116 N7b8d2c1c290049148003c95f803f4469 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Recombinant Proteins
118 rdf:type schema:DefinedTerm
119 N8a64f40209de4739ad200966e7933a36 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Polyethylene Glycols
121 rdf:type schema:DefinedTerm
122 N8fbdf6ab2ab6441ebd99f04ce40b42f7 schema:volumeNumber 33
123 rdf:type schema:PublicationVolume
124 N92196dc2268842ca82a854e7865c64ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Antineoplastic Combined Chemotherapy Protocols
126 rdf:type schema:DefinedTerm
127 N9398371741de4c20a238f81de4bd9607 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Adult
129 rdf:type schema:DefinedTerm
130 N99599cdf650e4b7bb94307e6cab40d9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Liver Neoplasms
132 rdf:type schema:DefinedTerm
133 N9b4125fcd98f44e880c777fdd49d04c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Response Evaluation Criteria in Solid Tumors
135 rdf:type schema:DefinedTerm
136 N9cab48efd3564640b7aa7ac72bb8204b rdf:first sg:person.011372244704.72
137 rdf:rest Na25be5476b4b4e31a89a2a1878440cac
138 Na25be5476b4b4e31a89a2a1878440cac rdf:first sg:person.01002234745.52
139 rdf:rest N74db9d927d8642a18d9626c9bcf17f5d
140 Nab209c9d57cf4c3d8b843b4180eb8f81 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Male
142 rdf:type schema:DefinedTerm
143 Nb34c4925ddcc4e249144ff4ec234f7d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Prospective Studies
145 rdf:type schema:DefinedTerm
146 Nb44eab0271e64a79a1841e478fd3233b schema:name pubmed_id
147 schema:value 25666409
148 rdf:type schema:PropertyValue
149 Nb8c37b3c20004f55b4c1c752026ad3fc schema:name doi
150 schema:value 10.1007/s10637-014-0200-8
151 rdf:type schema:PropertyValue
152 Nbf966be00f4d472d8d5d84e05f40b87c rdf:first sg:person.01036172252.41
153 rdf:rest Neb0c64af2e6f43b0aa14ab558266c650
154 Nc31f333db8184a0989e01154455477b3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Carcinoma, Hepatocellular
156 rdf:type schema:DefinedTerm
157 Nc493f2ed2ed0448cb8ac866cab000645 schema:name Springer Nature - SN SciGraph project
158 rdf:type schema:Organization
159 Nc5ceb3c7494e4a7a86300458012db02a rdf:first sg:person.07501676632.96
160 rdf:rest rdf:nil
161 Nc9604360bd9d420f8f095dd549f08d94 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Dose-Response Relationship, Drug
163 rdf:type schema:DefinedTerm
164 Nc9f6ca379747412b815232eaf207c9e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Aged
166 rdf:type schema:DefinedTerm
167 Ncbd093acada441b6b1ccb19ca35750ab schema:name dimensions_id
168 schema:value pub.1052798621
169 rdf:type schema:PropertyValue
170 Nd03ae116e26a4a739b9ab8f4bab0024d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Area Under Curve
172 rdf:type schema:DefinedTerm
173 Nd52b532d061740a19ef78314e03a5a3b schema:name Bio-Cancer Treatment International Limited, Hong Kong, China
174 rdf:type schema:Organization
175 Nd8d93d4188ba4c2c8de0ecf89a6af675 schema:name readcube_id
176 schema:value fb7edd20ac70be54e17006b72bb44b27f06d1537115edcd96ef363c494234538
177 rdf:type schema:PropertyValue
178 Nd9cc458be1554c77aad4643201146309 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Disease-Free Survival
180 rdf:type schema:DefinedTerm
181 Ndf642723438f47ea93a13afbd8ef0015 rdf:first sg:person.013420356062.81
182 rdf:rest N0346dd29b07941929d21ea438fd72cb7
183 Ne5a60f2740fb4ba0bcecac2bd82deda5 schema:name Bio-Cancer Treatment International Limited, Hong Kong, China
184 rdf:type schema:Organization
185 Ne72a8a14799546a0911aa3f08091dd15 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Middle Aged
187 rdf:type schema:DefinedTerm
188 Nea9811ee600f4903a2163f18e911484b schema:issueNumber 2
189 rdf:type schema:PublicationIssue
190 Neb0c64af2e6f43b0aa14ab558266c650 rdf:first sg:person.01353440362.56
191 rdf:rest Ndf642723438f47ea93a13afbd8ef0015
192 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
193 schema:name Medical and Health Sciences
194 rdf:type schema:DefinedTerm
195 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
196 schema:name Clinical Sciences
197 rdf:type schema:DefinedTerm
198 sg:journal.1094201 schema:issn 0167-6997
199 1573-0646
200 schema:name Investigational New Drugs
201 rdf:type schema:Periodical
202 sg:person.01002234745.52 schema:affiliation Nd52b532d061740a19ef78314e03a5a3b
203 schema:familyName Cheng
204 schema:givenName Paul N.
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002234745.52
206 rdf:type schema:Person
207 sg:person.01036172252.41 schema:affiliation Ne5a60f2740fb4ba0bcecac2bd82deda5
208 schema:familyName Chen
209 schema:givenName Li
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036172252.41
211 rdf:type schema:Person
212 sg:person.01111046126.83 schema:affiliation https://www.grid.ac/institutes/grid.194645.b
213 schema:familyName Fan
214 schema:givenName Sheung Tat
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01111046126.83
216 rdf:type schema:Person
217 sg:person.011372244704.72 schema:affiliation https://www.grid.ac/institutes/grid.194645.b
218 schema:familyName Yau
219 schema:givenName Thomas
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011372244704.72
221 rdf:type schema:Person
222 sg:person.01335216507.83 schema:affiliation N659556c3256a4810b66f7d0767804956
223 schema:familyName Wheatley
224 schema:givenName Denys N.
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335216507.83
226 rdf:type schema:Person
227 sg:person.013420356062.81 schema:affiliation https://www.grid.ac/institutes/grid.194645.b
228 schema:familyName Pang
229 schema:givenName Roberta
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013420356062.81
231 rdf:type schema:Person
232 sg:person.01353440362.56 schema:affiliation https://www.grid.ac/institutes/grid.414329.9
233 schema:familyName Yuen
234 schema:givenName Jimmy
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353440362.56
236 rdf:type schema:Person
237 sg:person.07501676632.96 schema:affiliation https://www.grid.ac/institutes/grid.194645.b
238 schema:familyName Poon
239 schema:givenName Ronnie T.
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07501676632.96
241 rdf:type schema:Person
242 sg:person.07742761162.25 schema:affiliation https://www.grid.ac/institutes/grid.416291.9
243 schema:familyName Chan
244 schema:givenName Pierre
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07742761162.25
246 rdf:type schema:Person
247 sg:pub.10.1007/s10637-012-9807-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025303725
248 https://doi.org/10.1007/s10637-012-9807-9
249 rdf:type schema:CreativeWork
250 sg:pub.10.1038/sj.bjc.6605856 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027168571
251 https://doi.org/10.1038/sj.bjc.6605856
252 rdf:type schema:CreativeWork
253 sg:pub.10.1186/1475-2867-9-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018933074
254 https://doi.org/10.1186/1475-2867-9-9
255 rdf:type schema:CreativeWork
256 sg:pub.10.1186/1756-8722-5-17 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041830204
257 https://doi.org/10.1186/1756-8722-5-17
258 rdf:type schema:CreativeWork
259 https://app.dimensions.ai/details/publication/pub.1074500177 schema:CreativeWork
260 https://app.dimensions.ai/details/publication/pub.1075086476 schema:CreativeWork
261 https://doi.org/10.1002/cncr.20057 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023655716
262 rdf:type schema:CreativeWork
263 https://doi.org/10.1002/cncr.23878 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040510533
264 rdf:type schema:CreativeWork
265 https://doi.org/10.1002/ijc.1440 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043886019
266 rdf:type schema:CreativeWork
267 https://doi.org/10.1002/ijc.22322 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026137659
268 rdf:type schema:CreativeWork
269 https://doi.org/10.1002/ijc.23723 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047559222
270 rdf:type schema:CreativeWork
271 https://doi.org/10.1002/ijc.2910510213 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038899862
272 rdf:type schema:CreativeWork
273 https://doi.org/10.1016/j.canlet.2004.10.050 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027789545
274 rdf:type schema:CreativeWork
275 https://doi.org/10.1016/j.canlet.2008.11.031 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017999696
276 rdf:type schema:CreativeWork
277 https://doi.org/10.1016/s0168-8278(01)00130-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021007716
278 rdf:type schema:CreativeWork
279 https://doi.org/10.1016/s1053-4296(03)00031-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017567845
280 rdf:type schema:CreativeWork
281 https://doi.org/10.1016/s1470-2045(08)70285-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018829845
282 rdf:type schema:CreativeWork
283 https://doi.org/10.1056/nejmoa0708857 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053513212
284 rdf:type schema:CreativeWork
285 https://doi.org/10.1093/jnci/92.3.205 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032301848
286 rdf:type schema:CreativeWork
287 https://doi.org/10.1093/jnci/dji315 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021808122
288 rdf:type schema:CreativeWork
289 https://doi.org/10.1097/00000658-200204000-00004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013218119
290 rdf:type schema:CreativeWork
291 https://doi.org/10.1097/00001813-200410000-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027805675
292 rdf:type schema:CreativeWork
293 https://doi.org/10.1097/00008390-199209000-00007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020661938
294 rdf:type schema:CreativeWork
295 https://doi.org/10.1111/j.1755-148x.2010.00798.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1012724924
296 rdf:type schema:CreativeWork
297 https://doi.org/10.1158/0008-5472.can-06-1945 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026108300
298 rdf:type schema:CreativeWork
299 https://doi.org/10.1182/blood-2009-12-258822 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019505412
300 rdf:type schema:CreativeWork
301 https://doi.org/10.1200/jco.2004.11.120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049804785
302 rdf:type schema:CreativeWork
303 https://doi.org/10.1200/jco.2012.44.5643 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022849249
304 rdf:type schema:CreativeWork
305 https://doi.org/10.1200/jco.2012.45.8372 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027910211
306 rdf:type schema:CreativeWork
307 https://doi.org/10.2174/156800912803988002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069191266
308 rdf:type schema:CreativeWork
309 https://www.grid.ac/institutes/grid.194645.b schema:alternateName University of Hong Kong
310 schema:name Centre for Cancer Research, The University of Hong Kong, Hong Kong, China
311 Department of Medicine, The University of Hong Kong, Hong Kong, China
312 Department of Surgery, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, China
313 State Key Laboratory for Liver Research, The University of Hong Kong, Hong Kong, China
314 rdf:type schema:Organization
315 https://www.grid.ac/institutes/grid.414329.9 schema:alternateName Hong Kong Sanatorium and Hospital
316 schema:name Hong Kong Sanatorium Hospital, Hong Kong, China
317 rdf:type schema:Organization
318 https://www.grid.ac/institutes/grid.416291.9 schema:alternateName Ruttonjee Hospital
319 schema:name Department of Medicine, Ruttonjee Hospital, Hong Kong, China
320 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...